Background: Previous work revealed the existence of a severe thymic atrophy with massive loss of immature CD4+CD8+ thymocytes in animals developing insulin-dependent diabetes, chemically induced by alloxan. Furthermore, the intrathymic expression of chemokines, such as CXCL12, is changed in these animals, suggesting that cell migration-related patterns may be altered. One molecular interaction involved in normal thymocyte migration is that mediated by soluble semaphorin-3A and its cognate receptor neuropilin-1. Objectives: We investigated herein the expression and role of semaphorin-3A in the migratory responses of thymocytes from alloxan-induced diabetic mice. We characterized semaphorin-3A and its receptor, neuropilin-1, in thymuses from control and diabetic mice as well as semaphorin-3A-dependent migration of developing thymocytes in both control and diabetic animals. Methods: Diabetes was chemically induced after a single injection of alloxan in young adult BALB/c mice. Thymocytes were excised from control and diabetic individuals and subjected to cytofluorometry for simultaneous detection of semaphorin-3A or neuropilin-1 in CD4/CD8-defined subsets. Cell migration in response to semaphorin-3A was performed using cell migration transwell chambers. Results: Confirming previous data, we observed a severe decrease in the total numbers of thymocytes in diabetic mice, which comprised alterations in both immature (double-negative subpopulations) and mature CD4/CD8-defined thymocyte subsets. These were accompanied by a decrease in the absolute numbers of semaphorin-3A-bearing thymocytes, comprising CD4CD8, CD4+CD8+, and CD4CD8+ cells. Additionally, immature CD4CD8 and CD4+CD8+ developing T cells exhibited a decrease in the membrane density of semaphorin-3A. The relative and absolute numbers of neuropilin-1-positive thymocytes were also decreased in diabetic mouse thymocytes compared to controls, as seen in CD4CD8, CD4+CD8+, and CD4CD8+ cell subpopulations. Functionally, we observed a decrease in the chemorepulsive role of semaphorin-3A, as revealed by transwell migration chambers. Such an effect was seen in all immature and mature thymocyte subsets. Conclusions: Taken together, our data clearly unravel a disruption in the normal cell migration pattern of developing thymocytes following chemically induced insulin-dependent diabetes, as ascertained by the altered migratory response to sempahorin-3A. In conceptual terms, it is plausible to think that such disturbances in the migration pattern of thymocytes from these diabetic animals may exert an impact in the cell-mediated immune response of these mice.

1.
Ciofani
M
,
Zúñiga-Pflücker
JC
.
The thymus as an inductive site for T lymphopoiesis
.
Annu Rev Cell Dev Biol
.
2007
;
23
(
1
):
463
93
.
[PubMed]
1081-0706
2.
Savino
W
,
Mendes-da-Cruz
DA
,
Lepletier
A
,
Dardenne
M
.
Hormonal control of T-cell development in health and disease
.
Nat Rev Endocrinol
.
2016
Feb
;
12
(
2
):
77
89
.
[PubMed]
1759-5029
3.
Anderson
G
,
Jenkinson
WE
,
Jones
T
,
Parnell
SM
,
Kinsella
FA
,
White
AJ
, et al.
Establishment and functioning of intrathymic microenvironments
.
Immunol Rev
.
2006
Feb
;
209
(
1
):
10
27
.
[PubMed]
0105-2896
4.
Petrie
HT
,
Zúñiga-Pflücker
JC
.
Zoned out: functional mapping of stromal signaling microenvironments in the thymus
.
Annu Rev Immunol
.
2007
;
25
(
1
):
649
79
.
[PubMed]
0732-0582
5.
Savino
W
,
Mendes-Da-Cruz
DA
,
Smaniotto
S
,
Silva-Monteiro
E
,
Villa-Verde
DM
.
Molecular mechanisms governing thymocyte migration: combined role of chemokines and extracellular matrix
.
J Leukoc Biol
.
2004
Jun
;
75
(
6
):
951
61
.
[PubMed]
0741-5400
6.
Mendes-da-Cruz
DA
,
Smaniotto
S
,
Keller
AC
,
Dardenne
M
,
Savino
W
.
Multivectorial abnormal cell migration in the NOD mouse thymus
.
J Immunol
.
2008
Apr
;
180
(
7
):
4639
47
.
[PubMed]
0022-1767
7.
Smaniotto
S
,
de Mello-Coelho
V
,
Villa-Verde
DM
,
Pléau
JM
,
Postel-Vinay
MC
,
Dardenne
M
, et al.
Growth hormone modulates thymocyte development in vivo through a combined action of laminin and CXC chemokine ligand 12
.
Endocrinology
.
2005
Jul
;
146
(
7
):
3005
17
.
[PubMed]
0013-7227
8.
Mendes-da-Cruz
DA
,
Stimamiglio
MA
,
Muñoz
JJ
,
Alfaro
D
,
Terra-Granado
E
,
García-Ceca
J
, et al.
Developing T-cell migration: role of semaphorins and ephrins
.
FASEB J
.
2012
Nov
;
26
(
11
):
4390
9
.
[PubMed]
0892-6638
9.
Lepelletier
Y
,
Smaniotto
S
,
Hadj-Slimane
R
,
Villa-Verde
DM
,
Nogueira
AC
,
Dardenne
M
, et al.
Control of human thymocyte migration by Neuropilin-1/Semaphorin-3A-mediated interactions
.
Proc Natl Acad Sci USA
.
2007
Mar
;
104
(
13
):
5545
50
.
[PubMed]
0027-8424
10.
Mendes-da-Cruz
DA
,
Lepelletier
Y
,
Brignier
AC
,
Smaniotto
S
,
Renand
A
,
Milpied
P
, et al.
Neuropilins, semaphorins, and their role in thymocyte development
.
Ann N Y Acad Sci
.
2009
Feb
;
1153
(
1
):
20
8
.
[PubMed]
0077-8923
11.
Garcia
F
,
Lepelletier
Y
,
Smaniotto
S
,
Hadj-Slimane
R
,
Dardenne
M
,
Hermine
O
, et al.
Inhibitory effect of semaphorin-3A, a known axon guidance molecule, in the human thymocyte migration induced by CXCL12
.
J Leukoc Biol
.
2012
Jan
;
91
(
1
):
7
13
.
[PubMed]
0741-5400
12.
Mendes-da-Cruz
DA
,
Brignier
AC
,
Asnafi
V
,
Baleydier
F
,
Messias
CV
,
Lepelletier
Y
, et al.
Semaphorin 3F and neuropilin-2 control the migration of human T-cell precursors
.
PLoS One
.
2014
Jul
;
9
(
7
):
e103405
.
[PubMed]
1932-6203
13.
Al-Awar
A
,
Kupai
K
,
Veszelka
M
,
Szűcs
G
,
Attieh
Z
,
Murlasits
Z
, et al.
Experimental Diabetes Mellitus in Different Animal Models
.
J Diabetes Res
.
2016
;
2016
:
9051426
.
[PubMed]
2314-6745
14.
Nagib
PR
,
Gameiro
J
,
Stivanin-Silva
LG
,
de Arruda
MS
,
Villa-Verde
DM
,
Savino
W
, et al.
Thymic microenvironmental alterations in experimentally induced diabetes
.
Immunobiology
.
2010
Dec
;
215
(
12
):
971
9
.
[PubMed]
0171-2985
15.
Ma
R
,
Wang
L
,
Zhao
B
,
Liu
C
,
Liu
H
,
Zhu
R
, et al.
Diabetes Perturbs Bone Microarchitecture and Bone Strength through Regulation of Sema3A/IGF-1/β-Catenin in Rats
.
Cell Physiol Biochem
.
2017
;
41
(
1
):
55
66
.
[PubMed]
1015-8987
16.
Koppel
AM
,
Feiner
L
,
Kobayashi
H
,
Raper
JA
.
A 70 amino acid region within the semaphorin domain activates specific cellular response of semaphorin family members
.
Neuron
.
1997
Sep
;
19
(
3
):
531
7
.
[PubMed]
0896-6273
17.
Yazdani
U
,
Terman
JR
.
The semaphorins
.
Genome Biol
.
2006
;
7
(
3
):
211
.
[PubMed]
1474-7596
18.
Kolodkin
AL
,
Levengood
DV
,
Rowe
EG
,
Tai
YT
,
Giger
RJ
,
Ginty
DD
.
Neuropilin is a semaphorin III receptor
.
Cell
.
1997
Aug
;
90
(
4
):
753
62
.
[PubMed]
0092-8674
19.
Smaniotto
S
,
Martins-Neto
AA
,
Dardenne
M
,
Savino
W
.
Growth hormone is a modulator of lymphocyte migration
.
Neuroimmunomodulation
.
2011
;
18
(
5
):
309
13
.
[PubMed]
1021-7401
20.
Savino
W
.
Intrathymic T cell migration is a multivectorial process under a complex neuroendocrine control
.
Neuroimmunomodulation
.
2010
;
17
(
3
):
142
5
.
[PubMed]
1021-7401
21.
Wu
LY
,
Li
M
,
Qu
ML
,
Li
X
,
Pi
LH
,
Chen
Z
, et al.
High glucose up-regulates Semaphorin 3A expression via the mTOR signaling pathway in keratinocytes: A potential mechanism and therapeutic target for diabetic small fiber neuropathy
.
Mol Cell Endocrinol
.
2018
Sep
;
472
:
107
16
.
[PubMed]
0303-7207
22.
Yamada
D
,
Kawahara
K
,
Ozaki
M
,
Maeda
T
.
Tumor cell-derives secretory factor downregulates Semaphorin-3a in osteoblasts by activating mammalian target of rapamycin pathway
.
Biochemistry & Molecular Biology
;
2016
. pp.
942
4
.
23.
Liu
YW
,
Zhang
L
,
Li
Y
,
Cheng
YQ
,
Zhu
X
,
Zhang
F
, et al.
Activation of mTOR signaling mediates the increased expression of AChE in high glucose condition: in vitro and in vivo evidences
.
Mol Neurobiol
.
2016
Sep
;
53
(
7
):
4972
80
.
[PubMed]
0893-7648
24.
Wu
J
,
Zhou
SL
,
Pi
LH
,
Shi
XJ
,
Ma
LR
,
Chen
Z
, et al.
High glucose induces formation of tau hyperphosphorylation via Cav-1-mTOR pathway: A potential molecular mechanism for diabetes-induced cognitive dysfunction
.
Oncotarget
.
2017
Jun
;
8
(
25
):
40843
56
.
[PubMed]
1949-2553
25.
Chapman
NM
,
Chi
H
.
mTOR links environmental signals to T cell fate decisions
.
Front Immunol
.
2015
Jan
;
5
:
686
.
[PubMed]
1664-3224
26.
Chi
H
.
Regulation and function of mTOR signalling in T cell fate decisions
.
Nat Rev Immunol
.
2012
Apr
;
12
(
5
):
325
38
.
[PubMed]
1474-1733
27.
Rutto
KV
,
Ovsyukov
KS
,
Kudryavtsev
IV
,
Kiseleva
EP
.
Semaphorin 3A negatively affects proliferation of mouse thymus epithelial cells in vitro
.
Bull Exp Biol Med
.
2019
Jan
;
166
(
3
):
339
43
.
[PubMed]
0007-4888
28.
Zhou
Z
,
Chen
Y
,
Zhang
H
,
Min
S
,
Yu
B
,
He
B
, et al.
Comparison of mesenchymal stromal cells from human bone marrow and adipose tissue for the treatment of spinal cord injury
.
Cytotherapy
.
2013
Apr
;
15
(
4
):
434
48
.
[PubMed]
1465-3249
29.
Alfaro
D
,
Muñoz
JJ
,
García-Ceca
J
,
Cejalvo
T
,
Jiménez
E
,
Zapata
A
.
Alterations in the thymocyte phenotype of EphB-deficient mice largely affect the double negative cell compartment
.
Immunology
.
2008
Sep
;
125
(
1
):
131
43
.
[PubMed]
0019-2805
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.